SlideShare a Scribd company logo
1 of 15
 Introduction
 Diagnosis
 Brief Pathology
 Treatment and Prognosis
 Other symptoms/complications
 Phases
 Other Neurodegenerative diseases
 Quiz
 PD is a movement disorder
› Prevalence: 100 – 180/100,000 in UK
› Incidence: 4 – 20/100,000 in UK
› M > F
 Parkinsonism – syndrome of:
› Bradykinesia (poverty of movement)
› Resting tremor
› Rigidity
› Varying degrees of postural instability
 Asymmetrical onset
 Slow progression
 Good response to L-dopa therapy
 N.B. only 60% develop tremor!
 Clinical – structural imaging normal
 Helpful signs:
› Micrographia
› Loss of arm swing
› Facial hypomimia (mask like)
› Cogwheel stiffness
› 4 – 7 Hz resting tremor
 Symmetrical onset
 Early falling
 Early cognitive impairment
 Prominent autonomic disturbance (sphincter
involvement)
 Pyramidal tract or cerebellar signs
Classic MCQ trick innit!
 Loss of dopamine producing cells in the
substantia nigra
 Also involves Serotonin, Acetylcholine and
Noradrenaline neurotransmitters
 Lewy bodies (intraneuronal protein inclusions)
 Most not genetic unless present < 30
› Parkin gene
 PD is progressive
 Pharmacological intervention changes as the
condition advances
 No universal first line treatment
› Patient choice and all that jazz!
Drug Group Examples Side Effects
Dopamine
Agonists
Bromocriptine
Pergolide
Cabergoline
Apomorphine
Pramipexole
Ropinorole
• Neuropsychiatric
• Ergots fibrosis
• Give Domperidone with
Apomorphine
• Hypotensive reactions
• SOOS and day sleepiness
Levodopa
Give with dopa-
decarboxylase
inhibitors
Co-careldopa (Sinemet)
(Ldopa + Carbidopa)
Co-benyldopa (Madopar)
(Ldopa + Benserazide)
• Response fluctuations ‘on-
off’
• Dyskinesias
• Anticholinergic
• Post. Hypotension
• Psychiatric
• N,V
MAOIs Selegiline
• Postural Hypotension
• Anticholinergic type
• Sleep disorders
• Confusion
• Nausea
Drug Group Example Side Effects
COMT Inhibitors
- Prevent peripheral
breakdown of Ldopa
- Can be used 1st line
according to NICE
Entacapone
Tolcapone
N,V
Diarrhoea, Constipation
Abdo pain
Urine goes red-brown
Dry mouth
Confusion
Insomnia etc
Amantidine
- Weak dopamine
agonist
- Antiviral
Amantadine
Hydrochloride
Anorexia
Nervousness
Insomnia
Reduced concentration
 Depression: 40%
› Note overlap with motor Sx of PD
 Autonomic disturbance and pain
› Constipation
› Postural Hypotension
 Significant disability
 Sleep disturbance
 Impotence
 Salivary problems
 Excessive sweating
 Urinary problems
 Cognitive problems – late!
Diagnosis  Refer to Specialists
› Medication may not be necessary
Maintenance  Medication prescribed
› Medications increase over time, monitor
› Essentially stable
Complex  Motor fluctuations: on-off/dyskinesia
› Other meds added: Amantadine, ?  agonist, ? add anti-psychotics
› Provide information support and advice, monitor regularly, prevent
psychotic symptoms! Avoid hospital admission
Palliative
› Medications less effective, may be no observable benefit. ?PEG – early.
› Symptom control, specialist services, end of life choices
 Parkinson Plus Syndromes:
› Multiple System Atrophy
› Progressive Supranuclear Palsy
› Dementia with Lewy Bodies
› Corticobasal degeneration
 Drug induced Parkinsonism:
› Neuroleptics
› Antiemetics – which one?
› Lithium
 Vascular Parkinsonism :
› Marked sparing of upper limbs
› Check vascular RF
Parksinson’s Disease:
 Is usually inherited
 Presents with early falling
 Should show a good response to L-dopa
 Can be treated with Deep Brain Stimulation
 Usually presents with symmetrical onset
 Constipation is a symptom
 NICE guidelines
 COMP2 presentations from blackboard…
grr!
 Medicine At a Glance.
 www.wikipedia.org
 www.meducation.net

More Related Content

What's hot

1362571948 diab cranial auto neuropathy(1)
1362571948 diab cranial auto neuropathy(1)1362571948 diab cranial auto neuropathy(1)
1362571948 diab cranial auto neuropathy(1)dfsimedia
 
GP Palliative Care Update 2019 GP Update Delirium - Dr. Paul McNamara
GP Palliative Care Update 2019 GP Update Delirium - Dr. Paul McNamaraGP Palliative Care Update 2019 GP Update Delirium - Dr. Paul McNamara
GP Palliative Care Update 2019 GP Update Delirium - Dr. Paul McNamaraSt Oswald's Hospice
 
Pharmacotherapy of sp and depressive disorders
Pharmacotherapy of sp and depressive disordersPharmacotherapy of sp and depressive disorders
Pharmacotherapy of sp and depressive disordersSaleem Cology
 
Complications of diabetes
Complications of diabetesComplications of diabetes
Complications of diabetesAdam Nickey
 
Toxicology pgy 1+2 2013
Toxicology pgy 1+2 2013Toxicology pgy 1+2 2013
Toxicology pgy 1+2 2013chricres
 
Anti epiletics drugs
Anti epiletics drugsAnti epiletics drugs
Anti epiletics drugsRavish Yadav
 
GP Palliative Care Update 2019 Neuropathic Pain Dr. Paul McNamara with thanks...
GP Palliative Care Update 2019 Neuropathic Pain Dr. Paul McNamara with thanks...GP Palliative Care Update 2019 Neuropathic Pain Dr. Paul McNamara with thanks...
GP Palliative Care Update 2019 Neuropathic Pain Dr. Paul McNamara with thanks...St Oswald's Hospice
 
GP Palliative Care Update 2019 Dyspnoea Dr. Robert McConnell (Speciality Doctor)
GP Palliative Care Update 2019 Dyspnoea Dr. Robert McConnell (Speciality Doctor)GP Palliative Care Update 2019 Dyspnoea Dr. Robert McConnell (Speciality Doctor)
GP Palliative Care Update 2019 Dyspnoea Dr. Robert McConnell (Speciality Doctor)St Oswald's Hospice
 
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's DiseaseAnti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's DiseaseKameshwaran Sugavanam
 
Neuropsychiatric Aspects of Parkinson's Disease
Neuropsychiatric Aspects of Parkinson's DiseaseNeuropsychiatric Aspects of Parkinson's Disease
Neuropsychiatric Aspects of Parkinson's DiseaseAbinayaa Arasu
 
Hypoglycemia Or Low Blood Sugar
Hypoglycemia Or Low Blood SugarHypoglycemia Or Low Blood Sugar
Hypoglycemia Or Low Blood SugarHealthy-ojas
 
Anti-Parkinson Drugs
Anti-Parkinson DrugsAnti-Parkinson Drugs
Anti-Parkinson Drugsvansh raina
 
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Soujanya Pharm.D
 
Substance abuse djorgenmorris
Substance abuse djorgenmorrisSubstance abuse djorgenmorris
Substance abuse djorgenmorrisdjorgenmorris
 

What's hot (20)

1362571948 diab cranial auto neuropathy(1)
1362571948 diab cranial auto neuropathy(1)1362571948 diab cranial auto neuropathy(1)
1362571948 diab cranial auto neuropathy(1)
 
Beers and brains
Beers and brainsBeers and brains
Beers and brains
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
GP Palliative Care Update 2019 GP Update Delirium - Dr. Paul McNamara
GP Palliative Care Update 2019 GP Update Delirium - Dr. Paul McNamaraGP Palliative Care Update 2019 GP Update Delirium - Dr. Paul McNamara
GP Palliative Care Update 2019 GP Update Delirium - Dr. Paul McNamara
 
Antiparkinsons
AntiparkinsonsAntiparkinsons
Antiparkinsons
 
Pharmacotherapy of sp and depressive disorders
Pharmacotherapy of sp and depressive disordersPharmacotherapy of sp and depressive disorders
Pharmacotherapy of sp and depressive disorders
 
Complications of diabetes
Complications of diabetesComplications of diabetes
Complications of diabetes
 
Toxicology pgy 1+2 2013
Toxicology pgy 1+2 2013Toxicology pgy 1+2 2013
Toxicology pgy 1+2 2013
 
Anti epiletics drugs
Anti epiletics drugsAnti epiletics drugs
Anti epiletics drugs
 
GP Palliative Care Update 2019 Neuropathic Pain Dr. Paul McNamara with thanks...
GP Palliative Care Update 2019 Neuropathic Pain Dr. Paul McNamara with thanks...GP Palliative Care Update 2019 Neuropathic Pain Dr. Paul McNamara with thanks...
GP Palliative Care Update 2019 Neuropathic Pain Dr. Paul McNamara with thanks...
 
GP Palliative Care Update 2019 Dyspnoea Dr. Robert McConnell (Speciality Doctor)
GP Palliative Care Update 2019 Dyspnoea Dr. Robert McConnell (Speciality Doctor)GP Palliative Care Update 2019 Dyspnoea Dr. Robert McConnell (Speciality Doctor)
GP Palliative Care Update 2019 Dyspnoea Dr. Robert McConnell (Speciality Doctor)
 
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's DiseaseAnti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
 
Neuropsychiatric Aspects of Parkinson's Disease
Neuropsychiatric Aspects of Parkinson's DiseaseNeuropsychiatric Aspects of Parkinson's Disease
Neuropsychiatric Aspects of Parkinson's Disease
 
Hypoglycaemia and funny turns
Hypoglycaemia and funny turnsHypoglycaemia and funny turns
Hypoglycaemia and funny turns
 
Hypoglycemia Or Low Blood Sugar
Hypoglycemia Or Low Blood SugarHypoglycemia Or Low Blood Sugar
Hypoglycemia Or Low Blood Sugar
 
Tremors for gp march 2019 copy
Tremors for gp march 2019   copyTremors for gp march 2019   copy
Tremors for gp march 2019 copy
 
Anti-Parkinson Drugs
Anti-Parkinson DrugsAnti-Parkinson Drugs
Anti-Parkinson Drugs
 
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
 
Substance abuse djorgenmorris
Substance abuse djorgenmorrisSubstance abuse djorgenmorris
Substance abuse djorgenmorris
 
Pharmacology of Alcohol
Pharmacology of Alcohol Pharmacology of Alcohol
Pharmacology of Alcohol
 

Viewers also liked

What Makes Us Do Failure Analysis - website
What Makes Us Do Failure Analysis - websiteWhat Makes Us Do Failure Analysis - website
What Makes Us Do Failure Analysis - websiteMichael S. (Mike) Beaton
 
Presentación adquisiciones
Presentación adquisicionesPresentación adquisiciones
Presentación adquisicionesRodrigoDC1959
 
Rural Health EBOP style... New Zealand rural health with a local flavour.
Rural Health EBOP style... New Zealand rural health with a local flavour.Rural Health EBOP style... New Zealand rural health with a local flavour.
Rural Health EBOP style... New Zealand rural health with a local flavour.meducationdotnet
 
Hoja nº 4 vocacional enero 14 15
Hoja nº 4 vocacional enero 14 15Hoja nº 4 vocacional enero 14 15
Hoja nº 4 vocacional enero 14 15Gines García
 
Dold earth leakage indicator
Dold earth leakage indicatorDold earth leakage indicator
Dold earth leakage indicatorSony Gunawan
 
Semana de prevenção e combate à aids é aberta com programação ampla no DF.
Semana de prevenção e combate à aids é aberta com programação ampla no DF.Semana de prevenção e combate à aids é aberta com programação ampla no DF.
Semana de prevenção e combate à aids é aberta com programação ampla no DF.Ministério da Saúde
 
ANUL BIBLIOLOGIC 2014 Top zece cele mai bune comunicări de la Concursul Repu...
 ANUL BIBLIOLOGIC 2014 Top zece cele mai bune comunicări de la Concursul Repu... ANUL BIBLIOLOGIC 2014 Top zece cele mai bune comunicări de la Concursul Repu...
ANUL BIBLIOLOGIC 2014 Top zece cele mai bune comunicări de la Concursul Repu...Vasilica Victoria
 
The Threat of Global Terrorism
The Threat of Global TerrorismThe Threat of Global Terrorism
The Threat of Global Terrorismmeducationdotnet
 
Every bug, its presentation, virulence, and treatment (NOW AMENDABLE)
Every bug, its presentation, virulence, and treatment (NOW AMENDABLE)Every bug, its presentation, virulence, and treatment (NOW AMENDABLE)
Every bug, its presentation, virulence, and treatment (NOW AMENDABLE)meducationdotnet
 
diavik-final_constructionbook-low
diavik-final_constructionbook-lowdiavik-final_constructionbook-low
diavik-final_constructionbook-lowKaren Marshall
 

Viewers also liked (14)

META_2.1_DEYTA
META_2.1_DEYTAMETA_2.1_DEYTA
META_2.1_DEYTA
 
What Makes Us Do Failure Analysis - website
What Makes Us Do Failure Analysis - websiteWhat Makes Us Do Failure Analysis - website
What Makes Us Do Failure Analysis - website
 
Presentación adquisiciones
Presentación adquisicionesPresentación adquisiciones
Presentación adquisiciones
 
Rural Health EBOP style... New Zealand rural health with a local flavour.
Rural Health EBOP style... New Zealand rural health with a local flavour.Rural Health EBOP style... New Zealand rural health with a local flavour.
Rural Health EBOP style... New Zealand rural health with a local flavour.
 
Hoja nº 4 vocacional enero 14 15
Hoja nº 4 vocacional enero 14 15Hoja nº 4 vocacional enero 14 15
Hoja nº 4 vocacional enero 14 15
 
Say not war
Say not warSay not war
Say not war
 
Dold earth leakage indicator
Dold earth leakage indicatorDold earth leakage indicator
Dold earth leakage indicator
 
Semana de prevenção e combate à aids é aberta com programação ampla no DF.
Semana de prevenção e combate à aids é aberta com programação ampla no DF.Semana de prevenção e combate à aids é aberta com programação ampla no DF.
Semana de prevenção e combate à aids é aberta com programação ampla no DF.
 
ANUL BIBLIOLOGIC 2014 Top zece cele mai bune comunicări de la Concursul Repu...
 ANUL BIBLIOLOGIC 2014 Top zece cele mai bune comunicări de la Concursul Repu... ANUL BIBLIOLOGIC 2014 Top zece cele mai bune comunicări de la Concursul Repu...
ANUL BIBLIOLOGIC 2014 Top zece cele mai bune comunicări de la Concursul Repu...
 
9 aspectos que
9 aspectos que9 aspectos que
9 aspectos que
 
The Threat of Global Terrorism
The Threat of Global TerrorismThe Threat of Global Terrorism
The Threat of Global Terrorism
 
Every bug, its presentation, virulence, and treatment (NOW AMENDABLE)
Every bug, its presentation, virulence, and treatment (NOW AMENDABLE)Every bug, its presentation, virulence, and treatment (NOW AMENDABLE)
Every bug, its presentation, virulence, and treatment (NOW AMENDABLE)
 
diavik-final_constructionbook-low
diavik-final_constructionbook-lowdiavik-final_constructionbook-low
diavik-final_constructionbook-low
 
Respiratory System
Respiratory SystemRespiratory System
Respiratory System
 

Similar to Parkinson's Disease

Problems in the management of epilepsy
Problems in the  management of epilepsyProblems in the  management of epilepsy
Problems in the management of epilepsyPS Deb
 
Pharmacotherapy of Parkinson’s disease
Pharmacotherapy of Parkinson’s diseasePharmacotherapy of Parkinson’s disease
Pharmacotherapy of Parkinson’s diseaseMayur Chaudhari
 
Parkinsons Disease
Parkinsons DiseaseParkinsons Disease
Parkinsons Diseasetest
 
Neurodegenerative Disorders Pharmacotherapy Dr Jayesh Vaghela
Neurodegenerative Disorders Pharmacotherapy Dr Jayesh VaghelaNeurodegenerative Disorders Pharmacotherapy Dr Jayesh Vaghela
Neurodegenerative Disorders Pharmacotherapy Dr Jayesh Vaghelajpv2212
 
Movement Disorders ShortNote
Movement Disorders ShortNoteMovement Disorders ShortNote
Movement Disorders ShortNoteKavindya Fernando
 
Parkinson's disease n management
Parkinson's disease n managementParkinson's disease n management
Parkinson's disease n managementDr. Rupendra Bharti
 
Parkisonism and anti parkinson's drugs
Parkisonism and anti parkinson's drugs Parkisonism and anti parkinson's drugs
Parkisonism and anti parkinson's drugs Hajra Matloob (RPH)
 
Chapter-6 CNS- PPT.pptx
Chapter-6 CNS- PPT.pptxChapter-6 CNS- PPT.pptx
Chapter-6 CNS- PPT.pptxjyotshnasahoo5
 
Parkinson’s Disease.pptx
Parkinson’s Disease.pptxParkinson’s Disease.pptx
Parkinson’s Disease.pptxMebratGebreyesus
 
Parkinsonism treatment
Parkinsonism treatmentParkinsonism treatment
Parkinsonism treatmentNaser Tadvi
 
MANAGEMENT OF PARKINSONISM BY Dr.HARMANJIT SINGH, DEPARTMENT OF PHARMACOLOGY,...
MANAGEMENT OF PARKINSONISM BY Dr.HARMANJIT SINGH, DEPARTMENT OF PHARMACOLOGY,...MANAGEMENT OF PARKINSONISM BY Dr.HARMANJIT SINGH, DEPARTMENT OF PHARMACOLOGY,...
MANAGEMENT OF PARKINSONISM BY Dr.HARMANJIT SINGH, DEPARTMENT OF PHARMACOLOGY,...Govt Medical College & Hospital, Sector-32
 
Neurodegenerative Drugs Pharma.pptx
Neurodegenerative Drugs Pharma.pptxNeurodegenerative Drugs Pharma.pptx
Neurodegenerative Drugs Pharma.pptxAymanshahzad4
 
Drug induced movement disorders
Drug induced movement disordersDrug induced movement disorders
Drug induced movement disordersPrerna Khar
 
Psychosis in parkinsons disease
Psychosis in parkinsons diseasePsychosis in parkinsons disease
Psychosis in parkinsons diseaseSara Temkit
 
ASandler_PD_Topic Discussion_8_30.docx
ASandler_PD_Topic Discussion_8_30.docxASandler_PD_Topic Discussion_8_30.docx
ASandler_PD_Topic Discussion_8_30.docxAnnaSandler4
 

Similar to Parkinson's Disease (20)

Antiparkinsons
AntiparkinsonsAntiparkinsons
Antiparkinsons
 
Problems in the management of epilepsy
Problems in the  management of epilepsyProblems in the  management of epilepsy
Problems in the management of epilepsy
 
Pharmacotherapy of Parkinson’s disease
Pharmacotherapy of Parkinson’s diseasePharmacotherapy of Parkinson’s disease
Pharmacotherapy of Parkinson’s disease
 
Parkinsons Disease
Parkinsons DiseaseParkinsons Disease
Parkinsons Disease
 
Neurodegenerative Disorders Pharmacotherapy Dr Jayesh Vaghela
Neurodegenerative Disorders Pharmacotherapy Dr Jayesh VaghelaNeurodegenerative Disorders Pharmacotherapy Dr Jayesh Vaghela
Neurodegenerative Disorders Pharmacotherapy Dr Jayesh Vaghela
 
Movement Disorders ShortNote
Movement Disorders ShortNoteMovement Disorders ShortNote
Movement Disorders ShortNote
 
Parkinson's disease n management
Parkinson's disease n managementParkinson's disease n management
Parkinson's disease n management
 
Parkisonism and anti parkinson's drugs
Parkisonism and anti parkinson's drugs Parkisonism and anti parkinson's drugs
Parkisonism and anti parkinson's drugs
 
Chapter-6 CNS- PPT.pptx
Chapter-6 CNS- PPT.pptxChapter-6 CNS- PPT.pptx
Chapter-6 CNS- PPT.pptx
 
Movement disorders
Movement disordersMovement disorders
Movement disorders
 
Parkinson diseases
Parkinson diseasesParkinson diseases
Parkinson diseases
 
Parkinson’s Disease.pptx
Parkinson’s Disease.pptxParkinson’s Disease.pptx
Parkinson’s Disease.pptx
 
2015 Good Start
2015 Good Start2015 Good Start
2015 Good Start
 
Parkinsonism treatment
Parkinsonism treatmentParkinsonism treatment
Parkinsonism treatment
 
MANAGEMENT OF PARKINSONISM BY Dr.HARMANJIT SINGH, DEPARTMENT OF PHARMACOLOGY,...
MANAGEMENT OF PARKINSONISM BY Dr.HARMANJIT SINGH, DEPARTMENT OF PHARMACOLOGY,...MANAGEMENT OF PARKINSONISM BY Dr.HARMANJIT SINGH, DEPARTMENT OF PHARMACOLOGY,...
MANAGEMENT OF PARKINSONISM BY Dr.HARMANJIT SINGH, DEPARTMENT OF PHARMACOLOGY,...
 
Neurodegenerative Drugs Pharma.pptx
Neurodegenerative Drugs Pharma.pptxNeurodegenerative Drugs Pharma.pptx
Neurodegenerative Drugs Pharma.pptx
 
Drug induced movement disorders
Drug induced movement disordersDrug induced movement disorders
Drug induced movement disorders
 
Psychosis in parkinsons disease
Psychosis in parkinsons diseasePsychosis in parkinsons disease
Psychosis in parkinsons disease
 
ASandler_PD_Topic Discussion_8_30.docx
ASandler_PD_Topic Discussion_8_30.docxASandler_PD_Topic Discussion_8_30.docx
ASandler_PD_Topic Discussion_8_30.docx
 
Parkinson's
Parkinson'sParkinson's
Parkinson's
 

More from meducationdotnet

More from meducationdotnet (20)

No Title
No TitleNo Title
No Title
 
Spondylarthropathy
SpondylarthropathySpondylarthropathy
Spondylarthropathy
 
Diagnosing Lung cancer
Diagnosing Lung cancerDiagnosing Lung cancer
Diagnosing Lung cancer
 
Eczema Herpeticum
Eczema HerpeticumEczema Herpeticum
Eczema Herpeticum
 
The Vagus Nerve
The Vagus NerveThe Vagus Nerve
The Vagus Nerve
 
Water and sanitation and their impact on health
Water and sanitation and their impact on healthWater and sanitation and their impact on health
Water and sanitation and their impact on health
 
The ethics of electives
The ethics of electivesThe ethics of electives
The ethics of electives
 
Intro to Global Health
Intro to Global HealthIntro to Global Health
Intro to Global Health
 
WTO and Health
WTO and HealthWTO and Health
WTO and Health
 
Globalisation and Health
Globalisation and HealthGlobalisation and Health
Globalisation and Health
 
Health Care Worker Migration
Health Care Worker MigrationHealth Care Worker Migration
Health Care Worker Migration
 
International Institutions
International InstitutionsInternational Institutions
International Institutions
 
Haemochromotosis brief overview
Haemochromotosis brief overviewHaemochromotosis brief overview
Haemochromotosis brief overview
 
Ascities overview
Ascities overviewAscities overview
Ascities overview
 
Overview of the Liver
Overview of the LiverOverview of the Liver
Overview of the Liver
 
Overview of Antidepressants
Overview of AntidepressantsOverview of Antidepressants
Overview of Antidepressants
 
Gout Presentation
Gout PresentationGout Presentation
Gout Presentation
 
Review of orthopaedic services: Prepared for the Auditor General for Scotland...
Review of orthopaedic services: Prepared for the Auditor General for Scotland...Review of orthopaedic services: Prepared for the Auditor General for Scotland...
Review of orthopaedic services: Prepared for the Auditor General for Scotland...
 
Sugammadex - a revolution in anaesthesia?
Sugammadex - a revolution in anaesthesia?Sugammadex - a revolution in anaesthesia?
Sugammadex - a revolution in anaesthesia?
 
Ophthamology Revision
Ophthamology RevisionOphthamology Revision
Ophthamology Revision
 

Parkinson's Disease

  • 1.
  • 2.  Introduction  Diagnosis  Brief Pathology  Treatment and Prognosis  Other symptoms/complications  Phases  Other Neurodegenerative diseases  Quiz
  • 3.  PD is a movement disorder › Prevalence: 100 – 180/100,000 in UK › Incidence: 4 – 20/100,000 in UK › M > F  Parkinsonism – syndrome of: › Bradykinesia (poverty of movement) › Resting tremor › Rigidity › Varying degrees of postural instability
  • 4.  Asymmetrical onset  Slow progression  Good response to L-dopa therapy  N.B. only 60% develop tremor!
  • 5.  Clinical – structural imaging normal  Helpful signs: › Micrographia › Loss of arm swing › Facial hypomimia (mask like) › Cogwheel stiffness › 4 – 7 Hz resting tremor
  • 6.  Symmetrical onset  Early falling  Early cognitive impairment  Prominent autonomic disturbance (sphincter involvement)  Pyramidal tract or cerebellar signs Classic MCQ trick innit!
  • 7.  Loss of dopamine producing cells in the substantia nigra  Also involves Serotonin, Acetylcholine and Noradrenaline neurotransmitters  Lewy bodies (intraneuronal protein inclusions)  Most not genetic unless present < 30 › Parkin gene
  • 8.  PD is progressive  Pharmacological intervention changes as the condition advances  No universal first line treatment › Patient choice and all that jazz!
  • 9. Drug Group Examples Side Effects Dopamine Agonists Bromocriptine Pergolide Cabergoline Apomorphine Pramipexole Ropinorole • Neuropsychiatric • Ergots fibrosis • Give Domperidone with Apomorphine • Hypotensive reactions • SOOS and day sleepiness Levodopa Give with dopa- decarboxylase inhibitors Co-careldopa (Sinemet) (Ldopa + Carbidopa) Co-benyldopa (Madopar) (Ldopa + Benserazide) • Response fluctuations ‘on- off’ • Dyskinesias • Anticholinergic • Post. Hypotension • Psychiatric • N,V MAOIs Selegiline • Postural Hypotension • Anticholinergic type • Sleep disorders • Confusion • Nausea
  • 10. Drug Group Example Side Effects COMT Inhibitors - Prevent peripheral breakdown of Ldopa - Can be used 1st line according to NICE Entacapone Tolcapone N,V Diarrhoea, Constipation Abdo pain Urine goes red-brown Dry mouth Confusion Insomnia etc Amantidine - Weak dopamine agonist - Antiviral Amantadine Hydrochloride Anorexia Nervousness Insomnia Reduced concentration
  • 11.  Depression: 40% › Note overlap with motor Sx of PD  Autonomic disturbance and pain › Constipation › Postural Hypotension  Significant disability  Sleep disturbance  Impotence  Salivary problems  Excessive sweating  Urinary problems  Cognitive problems – late!
  • 12. Diagnosis  Refer to Specialists › Medication may not be necessary Maintenance  Medication prescribed › Medications increase over time, monitor › Essentially stable Complex  Motor fluctuations: on-off/dyskinesia › Other meds added: Amantadine, ?  agonist, ? add anti-psychotics › Provide information support and advice, monitor regularly, prevent psychotic symptoms! Avoid hospital admission Palliative › Medications less effective, may be no observable benefit. ?PEG – early. › Symptom control, specialist services, end of life choices
  • 13.  Parkinson Plus Syndromes: › Multiple System Atrophy › Progressive Supranuclear Palsy › Dementia with Lewy Bodies › Corticobasal degeneration  Drug induced Parkinsonism: › Neuroleptics › Antiemetics – which one? › Lithium  Vascular Parkinsonism : › Marked sparing of upper limbs › Check vascular RF
  • 14. Parksinson’s Disease:  Is usually inherited  Presents with early falling  Should show a good response to L-dopa  Can be treated with Deep Brain Stimulation  Usually presents with symmetrical onset  Constipation is a symptom
  • 15.  NICE guidelines  COMP2 presentations from blackboard… grr!  Medicine At a Glance.  www.wikipedia.org  www.meducation.net

Editor's Notes

  1. Serotonin – mood and behaviour Acetylcholine – cognition and memory Noradrenalin – Autonomic function - BP
  2. Ergot derived dopamine agonists have been associated with pericardial, pulmonary and retroperitoneal fibrotic reactions. Before starting treatment it may be appropriate to measure ESR and serum creatinine and. Monitor for dyspnoea, persistent cough or chest pain, cardiac failure and abdominal tenderness. Start dose small and increase slowly. Do not stop abruptly Giving ldopa with decarboxylase inhibitors limits peripheral conversion to dopamine which would cause nausea and cardiovascular side effects. Avoud abrupt withdrawal because neuroleptic syndrome and rhabdomyolysis can occur.
  3. COMT = Catechol O methyltransferase inhibitors. Use as adjunct to Ldopa in PD and end of dose motor fluctuations.